Title: Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1.
Journal: The Journal of biological chemistry20140411
Title: N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
Journal: Behavioural brain research20120801
Title: The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.
Journal: Molecular pain20110101
Title: The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
Journal: Pharmacological research20100601
Title: Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.
Journal: Pharmacological research20100401
Title: Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Journal: Bioorganic & medicinal chemistry letters20091201
Title: Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
Journal: Neurobiology of disease20091001
Title: Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology20090201
Title: The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
Journal: Neuropharmacology20081201
Title: Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology20081101
Title: Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation.
Journal: Developmental neurobiology20081001
Title: Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system.
Journal: Developmental neurobiology20080915
Title: New N-arachidonoylserotonin analogues with potential 'dual' mechanism of action against pain.
Journal: Journal of medicinal chemistry20071227
Title: Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.
Journal: Journal of molecular medicine (Berlin, Germany)20071201
Title: Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
Journal: British journal of pharmacology20070801
Title: Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Journal: British journal of pharmacology20070301
Title: Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Journal: Biological psychiatry20060315
Title: Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
Journal: Neuropharmacology20060301
Title: Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology20060301
Title: Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.
Journal: Neuropharmacology20050901
Title: The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Journal: Journal of medicinal chemistry20050811
Title: Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.
Journal: Biochemical pharmacology20050801
Title: A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology20041001
Title: Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin.
Journal: Journal of enzyme inhibition and medicinal chemistry20030601
